PDCD1 and cancer: Combination of IL-12-expressing oncolytic herpes simplex virus (oHSV), which selectively replicates in cancer cells, with ICB antibodies (PD-1, CTLA-3, or PD-L1) slightly improved survival of a glioma mouse model.